Dymon Asia Capital »

BioMarin Pharmaceutical shares owned by Dymon Asia Capital

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Dymon Asia Capital from 13F filings

Historical chart of Dymon Asia Capital investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Dymon Asia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Dymon Asia Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $621k 11k 56.49

More positions owned by Dymon Asia Capital

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Ishares Tr Mbs Etf (MBB)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Lumentum Hldgs (LITE)
Alibaba Group Hldg Sponsored Ads (BABA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Vaneck Etf Trust Semiconductr Etf (SMH)
Ishares Silver Tr Ishares (SLV)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Msci Sth Afr Etf Call Option (EZA)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
UnitedHealth Call Option (UNH)
Microchip Technology (MCHP)

View all positions for Dymon Asia Capital

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
Dodge & Cox
PRIMECAP Management Company
Vanguard Capital Management
Vanguard Portfolio Management
AQR Capital Management
State Street Corporation
Viking Global Investors
Citadel Advisors
Geode Capital Management
Dimensional Fund Advisors
Vestal Point Capital
FMR
Capital Research Global Investors

View all funds holding BioMarin Pharmaceutical